Biotech entity

Oxford University

Company

All 1 tracked stories fall under one category: clinical-trial. Oxford University is most often covered alongside Bundibugyo virus, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Oxford University, all published on July 27, 2026.

Last mentioned: Jul 27, 2026

Entity pulse

Recent coverage · Oxford University

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Oxford University

All 1 tracked stories fall under one category: clinical-trial. Oxford University is most often covered alongside Bundibugyo virus, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Oxford University, all published on July 27, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Oxford University. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. 3,000 Cases Milestone

    Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.

  2. First Experimental Vaccine Volunteer Dosed

    Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.

  3. 2,000 Cases Surpassed

    Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.

  4. Outbreak Declared

    DR Congo announces its 17th Ebola outbreak, identifying the Bundibugyo strain as the cause.

Stories mentioning Oxford University 1

Clinical Trials Strongly negative

Ebola Outbreak Tops 3,000 Cases, Oxford Starts Clinical Trial for Bundibugyo Vaccine

DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.

2 sources

Source: english.aawsat.com · manilatimes.net

Oxford University is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.